Effect of ANKASCIN 568-P Products on Decreasing HbA1c and Regulating Blood Glucose
Effect of ANKASCIN 568-P Products on Decreasing HbA1c and Regulating Blood Glucose
Recruiting · NCT05737342 · Registry updated 2025-08-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effect of ANKASCIN 568-P Products on Decreasing HbA1c and Regulating Blood Glucose | Insulin Resistance, Nutritional and Metabolic Diseases, glucose metabolism disease, hyperglycemia, hyperinsulinism, metabolic disease | Recruiting | Not applicable | 2025-08-28 | NCT05737342 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| SunWay Biotech Co., LTD. | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tri-Service General Hospital, National Defense Medical Center, Taipei city, | Taipei | Taiwan | 2 |